An updated review of cucurbitacins and their biological and pharmacological activities

EXCLI Journal

Volumn 14, Issue , 2015, Pages 562-566

  Chung, Sun Ok ^a   Kim, Yong Joo ^a   Park, Sang Un ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; CUCURBITACIN; CUCURBITACIN B; CUCURBITACIN D; CUCURBITACIN E; CUCURBITACIN I; CUCURBITACIN IIB; CYCLIN B1; DOCETAXEL; GEMCITABINE; GOYAZENSOLIDE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; BLADDER CANCER CELL LINE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER INHIBITION; CELL PROLIFERATION; CHONDROSARCOMA; COLORECTAL CANCER CELL LINE; CYTOTOXICITY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; LETTER; LEUKEMIA CELL LINE; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; MYELOID LEUKEMIA; NEURILEMOMA; NON SMALL CELL LUNG CANCER; OSTEOSARCOMA; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84930208412     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: 10.17179/excli2015-283     Document Type: Letter

References (32)

1. Abbas S, Vincourt JB, Habib L, Netter P, Greige-Gerges H, Magdalou J. The cucurbitacins E, D and I: investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotrans-formation in man liver. Toxicol Lett. 2013;216:189-99.
2. Alghasham AA. Cucurbitacins - a promising target for cancer therapy. Int J Health Sci (Qassim). 2013;7: 77-89.
3. Aribi A, Gery S, Lee DH, Thoennissen NH, Thoen-nissen GB, Alvarez R, et al. The triterpenoid cucur-bitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. Int J Cancer. 2013;132:2730-7.
4. Chen X, Bao J, Guo J, Ding Q, Lu J, Huang M, et al. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Anticancer Drugs. 2012;23:777-87.
5. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, et al. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis. 2010;31:2097-104.
6. Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR, Patmasiriwat P. Antiprolif-erative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int J Mol Sci. 2010;11:5323-38.
7. Duangmano S, Sae-Lim P, Suksamrarn A, Domann FE, Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC Complement Altern Med. 2012; 12:185.
8. Feng H, Zang L, Zhao ZX, Kan QC. Cucurbitacin-E inhibits multiple cancer cells proliferation through attenuation of Wnt/β-catenin signaling. Cancer Biother Radiopharm. 2014;29:210-4.
9. Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactiva-tion of ATP citrate lyase by Cucurbitacin B: A bioac-tive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 2014;349:15-25.
10. Guo J, Wu G, Bao J, Hao W, Lu J, Chen X. Cucur-bitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One. 2014a;9:e88140.
11. Guo J, Zhao W, Hao W, Ren G, Lu J, Chen X. Cu-curbitacin B induces DNA damage, G2/M phase arrest, and apoptosis mediated by reactive oxygen species (ROS) in leukemia K562 cells. Anticancer Agents Med Chem. 2014b;14:1146-53.
12. Gupta P, Srivastava SK. Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression. Oncotarget. 2014;5:1812-28.
13. He J, Wang Y, Xu LH, Qiao J, Ouyang DY, He XH. Cucurbitacin IIa induces caspase-3-dependent apopto-sis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int Immuno-pharmacol. 2013;16:27-34.
14. Hsu YC, Huang TY, Chen MJ. Therapeutic ROS targeting of GADD45γ in the induction of G2/M arrest in primary human colorectal cancer cell lines by cu-curbitacin E. Cell Death Dis. 2014;5:e1198.
15. Hung CM, Chang CC, Lin CW, Ko SY, Hsu YC. Cu-curbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS. Int J Mol Sci. 2013;14:17147-56.
16. Jacquot C, Rousseau B, Carbonnelle D, Chinou I, Malleter M, Tomasoni C, et al. Cucurbitacin-D-induced CDK1 mRNA up-regulation causes proliferation arrest of a non-small cell lung carcinoma cell line (NSCLC-N6). Anticancer Res. 2014;34:4797-806.
17. Johnson MD, O'Connell MJ, Walter K. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and menin-gioma DNA synthesis. BMC Complement Altern Med. 2013;13:303.
18. Kausar H, Munagala R, Bansal SS, Aqil F, Vadhanam MV, Gupta RC. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets. Cancer Lett. 2013;332:35-45.
19. Kim SR, Seo HS, Choi HS, Cho SG, Kim YK, Hong EH, et al. Trichosanthes kirilowii ethanol extract and cucurbitacin d inhibit cell growth and induce apopto-sis through inhibition of stat3 activity in breast cancer cells. Evid Based Complement Alternat Med. 2013; 2013:975350.
20. Kong Y, Chen J, Zhou Z, Xia H, Qiu MH, Chen C. Cucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer. PLoS One. 2014;9:e103760.
21. Lan T, Wang L, Xu Q, Liu W, Jin H, Mao W, et al. Growth inhibitory effect of Cucurbitacin E on breast cancer cells. Int J Clin Exp Pathol. 2013;6:1799-805.
22. Ma J, Zi Jiang Y, Shi H, Mi C, Li J, Xing Nan J, et al. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α. Eur J Pharmacol. 2014; 723:46-54.
23. Qiao J, Xu LH, He J, Ouyang DY, He XH. Cucurbita-cin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-κB nuclear translocation. Inflamm Res. 2013;62:461-9.
24. Seo CR, Yang DK, Song NJ, Yun UJ, Gwon AR, Jo DG, et al. Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. Food Chem Toxicol. 2014;64:217-24.
25. Shang Y, Ma Y, Zhou Y, Zhang H, Duan L, Chen H, et al. Plant science. Biosynthesis, regulation, and domestication of bitterness in cucumber. Science. 2014; 346:1084-8.
26. Sörensen PM, Iacob RE, Fritzsche M, Engen JR, Brieher WM, Charras G, et al. The natural product cucurbitacin E inhibits depolymerization of actin filaments. ACS Chem Biol. 2012;7:1502-8.
27. Song Y, Ding N, Kanazawa T, Yamashita U, Yoshida Y. Cucurbitacin D is a new inflammasome activator in macrophages. Int Immunopharmacol. 2013;17: 1044-50.
28. Spear SA, Burns SS, Oblinger JL, Ren Y, Pan L, Kinghorn AD, et al. Natural compounds as potential treatments of NF2-deficient schwannoma andmenin-gioma: cucurbitacin D and goyazensolide. Otol Neu-rotol. 2013;34:1519-27.
29. Wang Y, Zhao GX, Xu LH, Liu KP, Pan H, He J, et al. Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes. PLoS One. 2014;9:e89751.
30. Yuan G, Yan SF, Xue H, Zhang P, Sun JT, Li G. Cu-curbitacin I induces protective autophagy in glioblas-toma in vitro and in vivo. J Biol Chem. 2014;289: 10607-19.
31. Zhang M, Bian ZG, Zhang Y, Wang JH, Kan L, Wang X, et al. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells. Mol Med Rep. 2014;10: 2905-11.
32. Zhang T, Li J, Dong Y, Zhai D, Lai L, Dai F, et al. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Breast Cancer Res Treat. 2012;135:445-58.